BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

458 related articles for article (PubMed ID: 11344201)

  • 1. Osteopenia in eugonadal men with acquired immune deficiency syndrome wasting syndrome.
    Fairfield WP; Finkelstein JS; Klibanski A; Grinspoon SK
    J Clin Endocrinol Metab; 2001 May; 86(5):2020-6. PubMed ID: 11344201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of lean body and muscle mass correlates with androgen levels in hypogonadal men with acquired immunodeficiency syndrome and wasting.
    Grinspoon S; Corcoran C; Lee K; Burrows B; Hubbard J; Katznelson L; Walsh M; Guccione A; Cannan J; Heller H; Basgoz N; Klibanski A
    J Clin Endocrinol Metab; 1996 Nov; 81(11):4051-8. PubMed ID: 8923860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increase in bone density and lean body mass during testosterone administration in men with acquired hypogonadism.
    Katznelson L; Finkelstein JS; Schoenfeld DA; Rosenthal DI; Anderson EJ; Klibanski A
    J Clin Endocrinol Metab; 1996 Dec; 81(12):4358-65. PubMed ID: 8954042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of androgen administration on the growth hormone-insulin-like growth factor I axis in men with acquired immunodeficiency syndrome wasting.
    Grinspoon S; Corcoran C; Stanley T; Katznelson L; Klibanski A
    J Clin Endocrinol Metab; 1998 Dec; 83(12):4251-6. PubMed ID: 9851759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced bone density in androgen-deficient women with acquired immune deficiency syndrome wasting.
    Huang JS; Wilkie SJ; Sullivan MP; Grinspoon S
    J Clin Endocrinol Metab; 2001 Aug; 86(8):3533-9. PubMed ID: 11502775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Body composition and endocrine function in women with acquired immunodeficiency syndrome wasting.
    Grinspoon S; Corcoran C; Miller K; Biller BM; Askari H; Wang E; Hubbard J; Anderson EJ; Basgoz N; Heller HM; Klibanski A
    J Clin Endocrinol Metab; 1997 May; 82(5):1332-7. PubMed ID: 9141512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exogenous testosterone or testosterone with finasteride increases bone mineral density in older men with low serum testosterone.
    Amory JK; Watts NB; Easley KA; Sutton PR; Anawalt BD; Matsumoto AM; Bremner WJ; Tenover JL
    J Clin Endocrinol Metab; 2004 Feb; 89(2):503-10. PubMed ID: 14764753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Osteopenia in HIV-infected women prior to highly active antiretroviral therapy.
    Teichmann J; Stephan E; Lange U; Discher T; Friese G; Lohmeyer J; Stracke H; Bretzel RG
    J Infect; 2003 May; 46(4):221-7. PubMed ID: 12799147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Body composition and muscle strength in healthy men receiving testosterone enanthate for contraception.
    Young NR; Baker HW; Liu G; Seeman E
    J Clin Endocrinol Metab; 1993 Oct; 77(4):1028-32. PubMed ID: 8408450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone loss in men with prostate cancer treated with gonadotropin-releasing hormone agonists.
    Stoch SA; Parker RA; Chen L; Bubley G; Ko YJ; Vincelette A; Greenspan SL
    J Clin Endocrinol Metab; 2001 Jun; 86(6):2787-91. PubMed ID: 11397888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of isolated hypogonadotropic hypogonadism effect on bone mineral density and bone turnover.
    Guo CY; Jones TH; Eastell R
    J Clin Endocrinol Metab; 1997 Feb; 82(2):658-65. PubMed ID: 9024272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of testosterone and progressive resistance training in eugonadal men with AIDS wasting. A randomized, controlled trial.
    Grinspoon S; Corcoran C; Parlman K; Costello M; Rosenthal D; Anderson E; Stanley T; Schoenfeld D; Burrows B; Hayden D; Basgoz N; Klibanski A
    Ann Intern Med; 2000 Sep; 133(5):348-55. PubMed ID: 10979879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fasting hyperinsulinemia in human immunodeficiency virus-infected men: relationship to body composition, gonadal function, and protease inhibitor use.
    Hadigan C; Corcoran C; Stanley T; Piecuch S; Klibanski A; Grinspoon S
    J Clin Endocrinol Metab; 2000 Jan; 85(1):35-41. PubMed ID: 10634360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of long-acting testosterone undecanoate on bone mineral density in middle-aged men with late-onset hypogonadism and metabolic syndrome: results from a 36 months controlled study.
    Aversa A; Bruzziches R; Francomano D; Greco EA; Fornari R; Di Luigi L; Lenzi A; Migliaccio S
    Aging Male; 2012 Jun; 15(2):96-102. PubMed ID: 22439807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of anorexia nervosa on bone metabolism in female adolescents.
    Soyka LA; Grinspoon S; Levitsky LL; Herzog DB; Klibanski A
    J Clin Endocrinol Metab; 1999 Dec; 84(12):4489-96. PubMed ID: 10599707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Androgen supplementation in eugonadal men with osteoporosis: effects of six months' treatment on markers of bone formation and resorption.
    Anderson FH; Francis RM; Peaston RT; Wastell HJ
    J Bone Miner Res; 1997 Mar; 12(3):472-8. PubMed ID: 9076591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of hypogonadism and testosterone administration on depression indices in HIV-infected men.
    Grinspoon S; Corcoran C; Stanley T; Baaj A; Basgoz N; Klibanski A
    J Clin Endocrinol Metab; 2000 Jan; 85(1):60-5. PubMed ID: 10634364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of low-dose alendronate treatment on bone mineral density and bone turnover markers in Chinese postmenopausal women with osteopenia and osteoporosis.
    Li M; Zhang ZL; Liao EY; Chen DC; Liu J; Tao TZ; Wu W; Xia WB; Lu YJ; Sheng ZF; Lu CY; Meng GL; Xu L; Zhang WJ; Hu YY; Xu L
    Menopause; 2013 Jan; 20(1):72-8. PubMed ID: 22968256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone marker and bone density responses to dopamine agonist therapy in hyperprolactinemic males.
    Di Somma C; Colao A; Di Sarno A; Klain M; Landi ML; Facciolli G; Pivonello R; Panza N; Salvatore M; Lombardi G
    J Clin Endocrinol Metab; 1998 Mar; 83(3):807-13. PubMed ID: 9506732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone mineral density in human immunodeficiency virus-1 infected men with hypogonadism prior to highly-active-antiretroviral-therapy (HAART).
    Teichmann J; Lange U; Discher T; Lohmeyer J; Stracke H; Bretzel RG
    Eur J Med Res; 2009; 14(2):59-64. PubMed ID: 19258214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.